MTNB - Matinas BioPharma Holdings, Inc.
0.576
-0.028 -4.774%
Share volume: 8,648
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$0.60
-0.03
-0.05%
View ratios
| Fiscal Date | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 11-13-2024 | 05-15-2025 | 08-14-2025 | 11-10-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 4.381 M | 1.946 M | 1.837 M | 1.577 M | |
| Selling general and admin | 2.142 M | 1.861 M | 1.837 M | 1.577 M | |
| Research and development | 2.239 M | 85.000 K | 0.000 | 0.000 | |
| Total expenses | 4.381 M | 1.946 M | 1.837 M | 1.577 M | |
| -55.58% | -5.60% | -14.15% | |||
| Operating income | -4.381 M | -1.946 M | -1.837 M | -1.577 M | |
| Ebit | -4.275 M | -1.652 M | -5.245 M | -1.532 M | |
| Pretax income | -4.275 M | -1.652 M | -5.245 M | -1.532 M | |
| -61.36% | 217.49% | -70.79% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -4.275 M | -1.656 M | -5.245 M | -1.532 M | |
| 61.26% | -216.73% | 70.79% |